Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HPC Specialty Infusion provides home-based specialty infusion pharmacy services, focusing on the administration of immune globulin therapies and coagulation factors for patients with primary immunodeficiency, autoimmune conditions, and bleeding disorders such as hemophilia. The company offers comprehensive patient support including medication delivery, nursing care, education on self-administration, insurance navigation, and 24/7 clinical support. No proprietary drug development or clinical trial results are reported; the company operates at a commercial service level.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HPC Specialty Infusion.